FDA approves new respiratory virus test

January 21, 2008

The U.S. Food and Drug Administration has approved a test that detects four respiratory viruses, including the flu, in a patient's respiratory secretions.

The ProFlu+ test provides results in as few as three hours. The FDA said other diagnostic tests for respiratory viruses are fast but not as accurate, or are as accurate but odn't givce results as quickly.

The real-time test employs a multiplex platform that allows several tests to be processed simultaneously using the same sample to detect influenza A virus, influenza B virus and respiratory syncytial virus A and B. Those viruses, said the FDA, can cause influenza, an infection of the airways called bronchiolitis, and pneumonia.

"Antiviral drugs are most effective when initiated within the first two days of symptoms," said Dr. Daniel Schultz, director of the FDA's Center for Devices and Radiological Health. "This new test, which is part of the new era of molecular medicine, can help the medical community quickly determine whether a respiratory illness is caused by one of these four viruses and initiate the appropriate treatment."

ProFlu+ is manufactured by Prodesse Inc. of Milwaukee.

Copyright 2008 by United Press International

Explore further: Vaccine for many common cold viruses achievable

Related Stories

Interferon shows promise as flu therapy

September 7, 2016

A molecule the body produces naturally in response to virus infection could be a viable flu treatment in the future, suggest researchers at the Francis Crick Institute in London.

CDC: 3 Miami businesses epicenter of 1st US Zika outbreak

September 23, 2016

The Zika outbreak in Miami's Wynwood arts district centered on three businesses with outdoor areas shared by employees, customers and breeding mosquitoes, and the number of people infected was likely greater than reported, ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.